Foghorn Therapeutics Inc. (FHTX)
NASDAQ: FHTX · Real-Time Price · USD
4.270
-0.100 (-2.29%)
At close: May 27, 2026, 4:00 PM EDT
4.290
+0.020 (0.47%)
After-hours: May 27, 2026, 7:01 PM EDT
Foghorn Therapeutics Stock Forecast
Stock Price Forecast
According to 10 analysts polled by S&P Global, Foghorn Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $11.44. The average 1-year stock price forecast is 167.92% higher than the current stock price, while the lowest is $9.00 (+110.77%) and the highest is $14 (+227.87%).
Price Target: $11.44 (+167.92%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Foghorn Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 9 | 9 | 9 | 9 | 9 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 10 | 10 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Buy Reiterates $10 | Buy | Reiterates | $10 | +134.19% | May 8, 2026 |
Unknown Analyst Guggenheim No rating | Guggenheim | Buy Maintains $12 | Buy | Maintains | $12 | +181.03% | May 8, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $13 | Buy | Reiterates | $13 | +204.45% | May 8, 2026 |
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 7, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $12 | Buy | Maintains | $12 | +181.03% | Apr 27, 2026 |
Financial Forecast
Revenue This Year
26.93M
from 30.91M
Decreased by -12.87%
Revenue Next Year
37.87M
from 26.93M
Increased by 40.63%
EPS This Year
-1.06
from -1.18
EPS Next Year
-0.98
from -1.06
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 42.0M | 53.8M | ||||||
| Avg | 26.9M | 37.9M | ||||||
| Low | n/a | 19.6M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 35.9% | 99.7% | ||||||
| Avg | -12.9% | 40.6% | ||||||
| Low | - | -27.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -0.81 | -0.70 | ||||||
| Avg | -1.06 | -0.98 | ||||||
| Low | -1.54 | -1.37 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.